Genedata develops and globally markets sophisticated computational solutions for drug discovery and related research processes in the life sciences. Genedata’s solutions enable scientists to efficiently process, integrate, analyze, and manage large and complex experimental data sets. Genedata provides software and professional services. Licenses are available for three enterprise software systems:
- Genedata Phylosopher® for Target Discovery applications
- Genedata Screener® for Lead Discovery applications
- Genedata Expressionist® for Biomarker Discovery applications
Founded in 1997, Genedata is a privately held Swiss Aktiengesellschaft with subsidiaries in Germany, the USA and Japan. Its offices are in Basel, Boston, San Francisco, Munich, Konstanz and Tokyo.
Genedata today includes over 100 highly qualified professionals with diverse backgrounds in the life as well as computational sciences who combine their expertise and experience to bring constant innovation to Genedata’s products.